Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Bourdeau

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Journal of Medical Genetics|January 31, 2020
Germline mutations in the new E1' cryptic exon of the <i>VHL</i> gene in patients with tumours of von Hippel-Lindau disease spectrum or with paragangliomaAlexandre Buffet, Bruna Calsina, Shahida Flores, et al.
JCI Insight|September 22, 2017
Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndromeAnne-Lise Lecoq, Constantine A Stratakis, Say Viengchareun, et al.
The Lancet. Diabetes & Endocrinology|October 16, 2021
Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort studyFanny Chasseloup, Isabelle Bourdeau, Antoine Tabarin, et al.
Research Square|July 9, 2024
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Nature Communications|March 18, 2025
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal IncidentalomaLetizia Canu, Janna A W Van Hemert, Michiel N Kerstens, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2023
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational studyMassimo Terzolo, Martin Fassnacht, Paola Perotti, et al.
European Journal of Endocrinology|June 9, 2025
Expert Consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous samplingMasanori Murakami, Mitsuhide Naruse, Hiroki Kobayashi, et al.
The Lancet. Diabetes & Endocrinology|April 3, 2023
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variantsDavid Taïeb, George B Wanna, Maleeha Ahmad, et al.
Nature Reviews. Endocrinology|December 14, 2023
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statementDavid Taïeb, Svenja Nölting, Nancy D Perrier, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Journal of Medical Genetics|January 31, 2020
Germline mutations in the new E1' cryptic exon of the <i>VHL</i> gene in patients with tumours of von Hippel-Lindau disease spectrum or with paragangliomaAlexandre Buffet, Bruna Calsina, Shahida Flores, et al.
JCI Insight|September 22, 2017
Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndromeAnne-Lise Lecoq, Constantine A Stratakis, Say Viengchareun, et al.
The Lancet. Diabetes & Endocrinology|October 16, 2021
Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort studyFanny Chasseloup, Isabelle Bourdeau, Antoine Tabarin, et al.
Research Square|July 9, 2024
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Nature Communications|March 18, 2025
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal IncidentalomaLetizia Canu, Janna A W Van Hemert, Michiel N Kerstens, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2023
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational studyMassimo Terzolo, Martin Fassnacht, Paola Perotti, et al.
European Journal of Endocrinology|June 9, 2025
Expert Consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous samplingMasanori Murakami, Mitsuhide Naruse, Hiroki Kobayashi, et al.
The Lancet. Diabetes & Endocrinology|April 3, 2023
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variantsDavid Taïeb, George B Wanna, Maleeha Ahmad, et al.
Nature Reviews. Endocrinology|December 14, 2023
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statementDavid Taïeb, Svenja Nölting, Nancy D Perrier, et al.
Pageof 13